IGF::OT::IGF Contract Award to Care Team Solutions, LLC: Using mHealth to Aid Opi

IGF::OT::IGF 合同授予 Care Team Solutions, LLC：利用移动医疗帮助 Opi

• 批准号: 8751431
• 负责人: Vesta Brue
• 金额: $ 14.93万
• 依托单位: CARE TEAM SOLUTIONS, LLC
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-08-01 至 2014-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8751431
• 关键词: Address; Adherence; Agonist; Award; Behavior; Buprenorphine; Caregivers; Caring; Contractor; Contracts; Evaluation; Focus Groups; Health; Hospitalization; Measures; Medication Management; Monitor; Naloxone; Names; Opiate Addiction; Opiates; Opioid Rotation; Participant; Patients; Pharmaceutical Preparations; Pharmacotherapy; Physicians; Relapse; Solutions; Thinking; cohort; medication compliance; mortality; usability

Opiate-agonist pharmacotherapy utilizing buprenorphine/naloxone is known to decrease illicit opiate use. However, poor medication management and misuse during self-managed opioid substitution therapy (OST) constrains efficacy, while aggrandizing relapse, hospitalizations and mortality. One of the most inescapable challenges confronted by professionals treating opioid dependence (OD) is assuring medications are taken as prescribed. Affording patients and physicians an interactive toolset to effectively monitor and promote adherence during OST represents a major unmet need that this project will address. Utilizing a forward-thinking approach in mobile health (mHealth) solutions, the Contractor will develop a smartphone application (APP), named SubAID, to engage and support patients and caregivers during OST to promote adherent behavior and provide timely assessment of adherence.

已知使用丁丙诺啡/纳洛酮的阿片激动剂药物治疗可减少 非法使用鸦片然而，在自我管理期间，药物管理不善和滥用 阿片替代疗法（OST）限制了疗效，同时加剧了复发， 住院和死亡率。面临的最不可避免的挑战， 治疗阿片类药物依赖（OD）的专业人员正在确保药物被视为 规定的。为患者和医生提供交互式工具集，以有效监测 并在OST期间促进遵守，这是一个主要的未满足的需求，该项目将 地址.利用移动的健康（mHealth）解决方案中的前瞻性思维方法， 承包商将开发一个名为SubAID的智能手机应用程序（APP）， 在OST期间支持患者和护理人员，以促进依从行为，并提供 及时评估遵守情况。